Indication
Antiplatelet Drugs
4 clinical trials
6 products
Clinical trial
Impact of Type 2 Diabetes on Outcomes Associated With Antiplatelet Drugs: A Retrospective AnalysisStatus: Completed, Estimated PCD: 2023-01-30
Product
Antiplatelet DrugClinical trial
Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac SurgeryStatus: Active (not recruiting), Estimated PCD: 2024-05-30
Product
AspirinProduct
No antiplatelet therapyClinical trial
Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow ConditionsStatus: Recruiting, Estimated PCD: 2026-05-01
Product
Blood samplingClinical trial
Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin Combined With Half-dose Ticagrelor in Patients With Unruptured Intracranial Aneurysms With Normal CYP2C19 Metabolizer PhenotypeStatus: Not yet recruiting, Estimated PCD: 2026-07-31
Product
Aspirin + ClopidogrelProduct
Aspirin + Ticagrelor